Bicara Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bicara Therapeutics Inc
CIK #0002023658
EDGAR Form CIK 2011 - 2026
10-K [0002023658]
10-Q [0002023658]
3 [0002023658]
4 [0002023658]
8-K [0002023658]
SC 13D [0002023658]
SC 13G [0002023658]
Form 13D/13G Filer Form 13D/13G Subject Filed
Janus Henderson Group PLC Bicara Therapeutics Inc [2026-05-15]
T Rowe Price Investment Management Inc Bicara Therapeutics Inc [2026-02-17]
Deep Track Capital LP Bicara Therapeutics Inc [2026-02-12]
FMR LLC Bicara Therapeutics Inc [2025-07-17]
Vestal Point Capital LP Bicara Therapeutics Inc [2025-05-15]
FMR LLC Bicara Therapeutics Inc [2025-03-03]
Invus Global Management LLC Bicara Therapeutics Inc [2024-09-26]
Red Tree GP LLC Bicara Therapeutics Inc [2024-09-26]
RA Capital Management LP Bicara Therapeutics Inc [2024-09-23]
TPG GP A LLC Bicara Therapeutics Inc [2024-09-18]
View All
Form 3/4/5 Subject 2011 - 2026
Bicara Therapeutics Inc
Simson Jake
Mazumdar-Shaw Kiran
Robertson Scott M
Powell Michael
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Nexus Fund III LP
RA Capital Management LP
Kolchinsky Peter
Bowden Christopher
Haviland Kate
Hyep Ivan
Mazumdar Claire
Cohlhepp Ryan
Schelman William
Raben David
Meisner Lara
Lonberg Nils
FIL Ltd
TPG GP A LLC
Coulter James G
Bonderman David
Winkelried Jon
FMR LLC
Deerfield Mgmt V LP
Deerfield Management Company LP
Deerfield Capital LP
Deerfield Private Design Fund V LP
Deerfield Partners LP
Flynn James E
Biocon Ltd
Biocon Pharma Inc
NG Carolyn
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-25 Sell 5,500 $18.95 104,225
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
2026-03-25 Option exercise 5,500 $0.00
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-25 Option exercise 5,500 $3.79 20,845
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-23 Sell 9,200 $18.52 170,384
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-23 Option exercise 9,200 $3.79 34,868
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
2026-03-23 Option exercise 9,200 $0.00
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-20 Sell 1,596 $18.95 30,244
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
2026-03-20 Option exercise 1,596 $0.00
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-20 Option exercise 1,596 $3.79 6,049
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-19 Option exercise 6,905 $3.79 26,170
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
2026-03-19 Option exercise 6,905 $0.00
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-19 Sell 6,905 $18.78 129,676
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
2026-03-18 Option exercise 6,499 $0.00
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-18 Sell 6,499 $18.84 122,441
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-18 Option exercise 6,499 $3.79 24,631
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-16 Sell 8,000 $19.66 157,280
Bicara Therapeutics Inc BCAX
Stock Option (Right to Buy) · derivative
2026-03-16 Option exercise 8,000 $0.00
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-16 Sell 4,500 $19.66 88,470
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-16 Option exercise 8,000 $3.79 30,320
Bicara Therapeutics Inc BCAX
Common Stock
2026-03-09 Option exercise 36,766 $3.79 139,343
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com